The Protective Effect of Different Dialysis Types on Residual Renal Function in Patients with Maintenance Hemodialysis: A Systematic Review and Meta-analysis

Overview

Journal Medicine (Baltimore)

Specialty General Medicine

Date 2018 Sep 15

PMID 30212979

Citations 13

Authors

Wenwen Lu

Chong Ren

Xin Han

Xiaoli Yang

Yanpei Cao

Bihong Huang

Affiliations

Soon will be listed here.

Abstract

Background: Residual renal function (RRF) is an important determinant of mortality and morbidity in patients undergoing hemodialysis. Different dialysis types may have different effects on RRF. We therefore conducted this meta-analysis to examine the RRF protective effect of different dialysis types for hemodialysis patients.

Methods: A systematic search was performed on PubMed, EMbase, Web of Science, Chinese Biomedical Literature Database, Wanfang database, and China National Knowledge Infrastructure for randomized controlled trials and cohort studies. Dialysis types included low-flux hemodialysis (LFHD), high-flux hemodialysis (HFHD), hemodiafiltration (HDF), and hemodialysis and hemoperfusion (HD+HP). The mean of endogenous creatinine clearance rate (CCR) and urea clearance rate (Curea), or urine volume was used to estimate RRF [95% confidence interval (95% CI), 6.05-16.80].

Results: There were 12 articles involving 1224 patients, including 11 random controlled trials and 1 cohort study. Meta-analysis showed that the RRF protective effect of HFHD [mean difference (MD) = 1.48, 95% CI (2.11 to 0.86), P < .01] and HD+HP [MD = 0.41, 95% CI (0.69 to 0.12), P = .005] was better than that of LFHD, and the RRF decline rate was the lowest in HFHD group [MD = 0.13, 95% CI (0.17 to 0.09), P < .01]. Descriptive analysis showed that HDF could better protect RRF when compared with LFHD. However, there was no consistency among other interventions when removing LFHD due to limited data.

Conclusion: For patients undergoing maintenance hemodialysis, the HFHD, HD+HP and HDF may better protect RRF, compared with LFHD.

Citing Articles

Blood purification therapy in chronic renal failure and its impact on renal index, serological index, and inflammatory factors.

Butt B, Mushtaq A, Hameed F, Abbasi M, Tariq M, Akbar A Ann Med Surg (Lond). 2024; 86(7):3856-3864.

PMID: 38989222 PMC: 11230819. DOI: 10.1097/MS9.0000000000002182.

Cause of death and influencing factors of chronic renal failure on maintenance hemodialysis.

Fan X, Li J, Bi Z, Liang W, Wang F Pak J Med Sci. 2023; 39(5):1378-1382.

PMID: 37680805 PMC: 10480753. DOI: 10.12669/pjms.39.5.7037.

Additional hemoperfusion for patients receiving maintenance hemodialysis: a retrospective analysis.

Li W, Wang J, Wang Y, Guan R, Zhao F, Zhang R Am J Transl Res. 2023; 15(6):4045-4054.

PMID: 37434811 PMC: 10331684.

Effects of high-flux hemodialysis and hemodiafiltration on the mortality of patients with end-stage kidney disease: a meta-analysis.

Ma S, Pu N, Ma J Ren Fail. 2023; 45(1):2147436.

PMID: 37427760 PMC: 10334859. DOI: 10.1080/0886022X.2022.2147436.

Altered gut microbiota and gut-derived p-cresyl sulfate serum levels in peritoneal dialysis patients.

Bao M, Zhang P, Guo S, Zou J, Ji J, Ding X Front Cell Infect Microbiol. 2022; 12:639624.

PMID: 36237423 PMC: 9551184. DOI: 10.3389/fcimb.2022.639624.

References

Caria S, Cupisti A, Sau G, Bolasco P . The incremental treatment of ESRD: a low-protein diet combined with weekly hemodialysis may be beneficial for selected patients. BMC Nephrol. 2014; 15:172. PMC: 4232716. DOI: 10.1186/1471-2369-15-172. View

Moist L, Port F, Orzol S, Young E, Ostbye T, Wolfe R . Predictors of loss of residual renal function among new dialysis patients. J Am Soc Nephrol. 2000; 11(3):556-564. DOI: 10.1681/ASN.V113556. View

de Jager D, Grootendorst D, Jager K, van Dijk P, Tomas L, Ansell D . Cardiovascular and noncardiovascular mortality among patients starting dialysis. JAMA. 2009; 302(16):1782-9. DOI: 10.1001/jama.2009.1488. View

Cai W, Miao S, Wang P, Xing L . [Efficacy and mechanism of hemoperfusion plus hemodialysis for peripheral neuropathy of uremic patients on maintenance hemodialysis]. Zhonghua Yi Xue Za Zhi. 2015; 95(17):1319-22. View

Hyodo T, Koutoku N . Preservation of residual renal function with HDF. Contrib Nephrol. 2010; 168:204-212. DOI: 10.1159/000321762. View

Suda T, Hiroshige K, Ohta T, Watanabe Y, Iwamoto M, Kanegae K . The contribution of residual renal function to overall nutritional status in chronic haemodialysis patients. Nephrol Dial Transplant. 2000; 15(3):396-401. DOI: 10.1093/ndt/15.3.396. View

Yohanna S, Alkatheeri A, Brimble S, McCormick B, Iansavitchous A, Blake P . Effect of Neutral-pH, Low-Glucose Degradation Product Peritoneal Dialysis Solutions on Residual Renal Function, Urine Volume, and Ultrafiltration: A Systematic Review and Meta-Analysis. Clin J Am Soc Nephrol. 2015; 10(8):1380-8. PMC: 4527022. DOI: 10.2215/CJN.05410514. View

Lew S . How to measure residual renal function in patients on maintenance hemodialysis. Adv Ren Replace Ther. 1994; 1(2):185-93. DOI: 10.1016/s1073-4449(12)80050-1. View

Rosselli D, Rueda J, Diaz C . Cost-effectiveness of kidney transplantation compared with chronic dialysis in end-stage renal disease. Saudi J Kidney Dis Transpl. 2015; 26(4):733-8. DOI: 10.4103/1319-2442.160175. View

10.

Mathew A, Fishbane S, Obi Y, Kalantar-Zadeh K . Preservation of residual kidney function in hemodialysis patients: reviving an old concept. Kidney Int. 2016; 90(2):262-271. PMC: 5798008. DOI: 10.1016/j.kint.2016.02.037. View

11.

Luctkar-Flude M, Groll D . A Systematic Review of the Safety and Effect of Neurofeedback on Fatigue and Cognition. Integr Cancer Ther. 2015; 14(4):318-40. DOI: 10.1177/1534735415572886. View

12.

Haynes R, Staplin N, Emberson J, Herrington W, Tomson C, Agodoa L . Evaluating the contribution of the cause of kidney disease to prognosis in CKD: results from the Study of Heart and Renal Protection (SHARP). Am J Kidney Dis. 2014; 64(1):40-8. PMC: 4068325. DOI: 10.1053/j.ajkd.2013.12.013. View

13.

Penne E, van der Weerd N, Grooteman M, Mazairac A, van den Dorpel M, Nube M . Role of residual renal function in phosphate control and anemia management in chronic hemodialysis patients. Clin J Am Soc Nephrol. 2010; 6(2):281-9. PMC: 3052217. DOI: 10.2215/CJN.04480510. View

14.

Palmer S, Palmer A, Craig J, Johnson D, Stroumza P, Frantzen L . Home versus in-centre haemodialysis for end-stage kidney disease. Cochrane Database Syst Rev. 2014; (11):CD009535. PMC: 7390476. DOI: 10.1002/14651858.CD009535.pub2. View

15.

Schiffl H, Lang S, Fischer R . Effects of high efficiency post-dilution on-line hemodiafiltration or conventional hemodialysis on residual renal function and left ventricular hypertrophy. Int Urol Nephrol. 2012; 45(5):1389-96. DOI: 10.1007/s11255-012-0336-4. View

16.

Tanaka M, Yamashita T, Koyama M, Moniwa N, Ohno K, Mitsumata K . Impact of use of angiotensin II receptor blocker on all-cause mortality in hemodialysis patients: prospective cohort study using a propensity-score analysis. Clin Exp Nephrol. 2015; 20(3):469-78. DOI: 10.1007/s10157-015-1182-3. View

17.

Lang S, Bergner A, Topfer M, Schiffl H . Preservation of residual renal function in dialysis patients: effects of dialysis-technique-related factors. Perit Dial Int. 2001; 21(1):52-7. View

18.

Chen H, Chou C, Jheng J, Chen I, Liang C, Wang S . Loss of Residual Renal Function is Associated With Vascular Calcification in Hemodialysis Patients. Ther Apher Dial. 2015; 20(1):27-30. DOI: 10.1111/1744-9987.12376. View

19.

Davenport A . Will incremental hemodialysis preserve residual function and improve patient survival?. Semin Dial. 2014; 28(1):16-9. PMC: 4320773. DOI: 10.1111/sdi.12320. View

20.

Brener Z, Thijssen S, Kotanko P, Kuhlmann M, Bergman M, Winchester J . The impact of residual renal function on hospitalization and mortality in incident hemodialysis patients. Blood Purif. 2011; 31(4):243-51. DOI: 10.1159/000322252. View